معرفی
Yi-Guang Chen is a Professor at the Medical College of Wisconsin, holding dual affiliations in Microbiology & Immunology and Pediatrics (Endocrinology). His research focuses on understanding the genetic and immunological mechanisms underlying Type 1 Diabetes (T1D), particularly leveraging the Non-Obese Diabetic (NOD) mouse model to study susceptibility genes and therapeutic interventions.
Education includes a PhD in Pathology and Laboratory Medicine from the University of Rochester (2002) and a BS from National Taiwan University (1993).
Research interests emphasize three pillars: identifying T1D susceptibility genes, evaluating pharmaceutical targeting of these genes, and assessing gene-modulated responses to therapies. Key methodologies include genetic modification of NOD mice to analyze gene function in diabetes progression and leveraging single-cell RNA sequencing (scRNA-seq) for mechanistic insights.
Recent publications highlight advancements in bioinformatics tools for scRNA-seq (e.g., FastQDesign), immune cell subset characterization (e.g., IL-21+ CD4 T cells, monocyte subsets), and cytokine-driven pathways (e.g., IL-27, IL-13). These studies underscore roles in autoimmune processes, diabetic complications, and translational therapeutic strategies.
Chen’s work bridges basic immunology with clinical applications, aiming to uncover pathways for disease prevention and reversal. His team actively explores probiotic modulation of β-cell stress and gene-editing approaches to dissect autoimmune mechanisms.
